Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Join | Sign in
Home>Resources>Webcasts>This Webcast
  Webcasts

Embryonic Stem Cells: Tools for Drug Discovery and Development

Ralph Snodgrass, CEO, VistaGen Therapeutics, speaking at the Stem Cells World Congress 2007
Date Posted: Tuesday, May 20, 2008
Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Related Content

VistaGen Secures Key U.S. Stem Cell Technology Patent
United States patent covers the company's proprietary methods used to measure and type the toxic effects produced by drug compounds in liver stem cells.
Thursday, April 26, 2012
VistaGen Increases Its Drug Rescue Opportunities
Long-term relationship with global contract research and development organization expands to include right-of-first-offer for potential drug rescue candidates.
Thursday, February 09, 2012
VistaGen Therapeutics and University Health Network Extend Collaborative Stem Cell Research
Alliance Supports Drug Rescue Initiatives, Cell Therapy Applications, and Focus on Large-Scale Production of Stem Cells
Thursday, November 17, 2011
VistaGen Therapeutics Reports Advances in its Pancreatic Cell and Regenerative Medicine Programs
Use of pluripotent stem cells to generate insulin in mice.
Tuesday, September 27, 2011
VistaGen Therapeutics Provides Investor Update on Corporate Activities and Upcoming Initiatives
VistaGen provides comprehensive update on the Company's strategic plan to develop and commercialize its technology platform and lead small molecule CNS drug candidate.
Friday, September 16, 2011
Vistagen Therapeutics Announces Publications Supporting the Use of Embryonic Stem Cells
The publications highlight advances to understand how embryonic stem cells can be reproducibly differentiated into heart and liver cells.
Thursday, December 28, 2006
Scientific News
Inexpensive Technique Developed to Manufacture Nanofibers
Current methods for producing nanofibers are incredibly costly and therefore limit accessibility, this new study opens the door to cheap, mass produced nanofibers.
Designing Better Medical Implants
A team of MIT researchers have discovered a novel method for reducing the typical immune system rejection response when implanting biomedical devices into the body.
UB and Roswell Park receive $1.85M Grant to Launch Stem Cell Research Program
The program will bring together 18 faculty members to advance translation of stem cell breakthroughs into cell therapies.
Hydrogels Help Stem Cells Accelerate Healing
Scientists say they have made a breakthrough in cell transplantation using a gel-like biomaterial that keeps stem cells alive and helps them integrate better into tissue.
Drug Perks up Old Muscles and Aging Brains
Whether you’re brainy, brawny or both, you may someday benefit from a drug found to rejuvenate aging brain and muscle tissue.
Dying Cells Can Protect their Stem Cells from Destruction
An SOS signal from dying daughter cells allows their mother stem cells to protect themselves from radiation and chemotherapy damage.
New Stem Cell May Overcome Hurdles for Regenerative Medicine
Scientists have discovered a novel type of pluripotent stem cell capable of developing into any type of tissue whose identity is tied to their location in a developing embryo.
New Anti-Cancer Stem Cell Compound In Development
Cardiff University scientists discover compound capable of fighting cancer on multiple fronts.
Vital Step in Stem Cell Growth Revealed
Salk scientists' finding could aid regenerative and cancer therapies.
Odd Histone Helps Suppress Jumping Genes in Stem Cells, Study Says
Research reveals a basic mechanism by which epigenetics, or the control of inherited traits through means other than DNA, works.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters